← Evidence map

ReviewAustralian prescriber2020

Harms and benefits of sodium-glucose co-transporter 2 inhibitors.

Thomas Chesterman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33093744